Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-04-20
1989-05-16
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544279, 544229, A61K 31505, C07D47104, C07F 708
Patent
active
048310379
ABSTRACT:
N-[4-(N'-[2-amino-4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-ylme thyl]-N'-acylamino)benzoyl]-L-glutamic acid derivatives are antineoplastic agents. The compounds are prepared through acylation of the corresponding N'-amino compound or hydrolysis of a protected N'-acylamino compound. A typical embodiment is N-[4-(N'-[2-amino-4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-ylm ethyl]-N'-formylamino)benzoyl]-L-glutamic acid.
REFERENCES:
patent: 4684653 (1987-08-01), Taylor et al.
Dedhar et al., Biochemical Pharmacology 32, pp. 922-924 (1983).
Dedhar et al., Chem. Abstract No. 16099u, vol. 99 (1983).
Taylor et al., J. Org. Chem. 48, p. 4852 (1983).
Temple et al., J. Med. Chem. 24, p. 1254 (1981).
Beardsley George P.
Hamby James M.
Taylor Edward C.
Bernhardt E.
Collins Bruce M.
Daus Donald G.
The Trustees of Princeton University
LandOfFree
4 (3H)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4 (3H)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4 (3H)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2322839